-
Lysosomal Exocytosis in MPS IVA Cartilage
2026-09-05
The reference study identifies enhanced lysosomal exocytosis as a contributor to cartilage pathology in a zebrafish model of mucopolysaccharidosis type IVA, extending the disease mechanism beyond macromolecular storage. Its comparison with sialidosis reveals that increased exocytosis can produce disease-specific changes in cathepsin activity, glycosaminoglycan distribution, and TGFβ/BMP signaling.
-
Caffeic Acid Phenethyl Ester in NF-κB Assays
2026-09-04
Caffeic Acid Phenethyl Ester (CAPE) provides a practical way to perturb NF-κB signaling in cell, tumor, and exploratory neurodegeneration workflows. Its value is greatest when pathway inhibition is paired with viability, inflammatory, angiogenic, or invasion readouts rather than interpreted from a single endpoint.
-
Oxidative Stress, Ferroptosis, and TSC Mitophagy
2026-09-04
The reference study identifies a mechanistic link between oxidative stress, cGAS-STING signaling, mitophagy, and ferroptosis in tendon stem cells. Its cell and rat experiments suggest that cGAS-driven mitochondrial quality-control changes contribute to tendon injury and may provide a more selective therapeutic direction than broadly targeting cell death.
-
Physiological and Pathological Aβ in Human Synapses
2026-09-03
This study uses live human brain slice cultures to distinguish how endogenous physiological amyloid-β and Alzheimer’s disease-associated amyloid-β affect synapses. Its central contribution is showing that both excessive and reduced physiological Aβ can disrupt synaptophysin puncta, whereas pathological Aβ produces a distinct pattern involving postsynaptic uptake and presynaptic loss without the same synaptic transcript response.
-
Metal-Free Carbon Nanozymes for ALP Detection
2026-09-03
The reference study develops a metal-free carbon-dot nanozyme assay in which alkaline phosphatase hydrolysis of pyrophosphate releases catalytic activity and produces a colorimetric turn-on signal. Its kinetic analysis identifies pyrophosphate as a noncompetitive inhibitor acting at a site distinct from the carbon-dot catalytic center, enabling sensitive ALP measurement with reduced risk of metal-associated interference.
-
DiscoveryProbe FDA-approved Drug Library for TNBC Screening
2026-09-02
Use 2,320 clinically validated compounds to build a practical TNBC resistance-screening workflow around EGFR-TKI response, oxidative phosphorylation, and cancer stem-cell phenotypes. The pre-dissolved 10 mM format supports rapid drug repositioning screening, while orthogonal viability, metabolic, and imaging assays help distinguish pathway-linked sensitizers from nonspecific cytotoxins.
-
WSP-5 for Live-Cell H2S Imaging
2026-09-02
WSP-5 converts transient hydrogen sulfide exposure into a rapid green fluorescent signal, giving researchers spatial and temporal information that bulk sulfide assays can miss. This guide translates diabetic cardiomyopathy findings into practical workflows for donor testing, lipotoxicity models, and cancer cell model imaging.
-
DAMGO Workflows for µ-Opioid Receptor Research
2026-09-01
DAMGO links receptor-proximal assays with circuit-level studies of opioid-induced mechanical hypersensitivity and tolerance. This practical guide shows how to use a selective µ-opioid receptor agonist in membrane signaling, ex vivo tissue, and mouse pain-circuit workflows while avoiding common interpretation errors.
-
Nutlin-3a: MDM2 Inhibitor Mechanism & Uses
2026-09-01
Nutlin-3a is a small-molecule MDM2 inhibitor that occupies the TP53-binding pocket and supports p53 pathway activation. It is a research tool for studying cell cycle arrest, apoptosis induction, and genotype-dependent responses in cancer models.
-
MLN4924 Workflow for Neddylation Research
2026-08-31
MLN4924 provides a selective way to interrogate NAE-dependent protein degradation, from rapid cullin target engagement to cell-cycle and tumor-model phenotypes. Its use as a pathway perturbation tool also enables mechanistic testing of the DCAF7–CRL4B antiviral axis, while highlighting why context and assay timing matter.
-
Bovine Insulin for Stress-Aware Cell Culture
2026-08-31
Bovine insulin is more than a routine media supplement: it is a controllable metabolic variable in reproducible cell culture. This guide connects insulin from bovine pancreas with ER-stress-aware assay design, using recent HBV–HMGB1 research to sharpen interpretation without overstating translational evidence.
-
Metformin Hydrochloride in AMPK Fibrosis Research
2026-08-30
Metformin Hydrochloride is a practical tool for connecting metabolic regulation with tissue remodeling. This workflow translates rabbit vocal fold fibrosis findings into assay-ready choices for AMPK, TGF-β, collagen, and glucose-metabolism studies while highlighting controls and reproducibility limits.
-
QPRT, P2Y11, and Breast Cancer Invasion
2026-08-29
The reference study identifies quinolinate phosphoribosyltransferase (QPRT) as a driver of breast cancer cell migration and invasion, linking altered NAD+ metabolism to myosin light chain phosphorylation and purinergic signaling. Its genetic and pharmacological experiments position P2Y11-linked signaling as a mechanistic research target, while also showing why the findings require validation across tumor models and clinical cohorts.
-
miR-18a–ALOXE3 Axis in Glioblastoma
2026-08-28
Yang et al. identify a miR-18a–ALOXE3 regulatory axis that links lipid metabolism to ferroptosis resistance and glioblastoma-cell migration. Their human-tumor analyses, cellular perturbations, lipid mediator studies, and orthotopic models support ALOXE3 as a mechanistic tumor suppressor rather than merely a disease-associated marker.
-
RNAi Screen Reveals SARS-CoV-2 Release Factors
2026-08-28
Kerr et al. developed an arrayed, druggable-genome RNA interference screen that measured SARS-CoV-2 production at multiple stages of the replication and reinfection cycle. The study identifies Rab11a-linked vesicular transport as a conserved proviral pathway and shows that CDK9 inhibition can block viral release, while also clarifying the experimental limits of host-targeted antiviral interpretation.